Small molecule NF-κB inhibitors
US10660894B2 · kind B2 · utility
0Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2019 |
| Grant date | May 26, 2020 |
| Priority date | — |
| Expiry date | Jan 10, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, inter alia, compounds capable of inhibiting NF-κB. Pharmaceutical compositions containing and methods of using the compounds are also provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.